Carregant...
Preoperative Molecular Markers in Thyroid Nodules
The need for distinguishing benign from malignant thyroid nodules has led to the pursuit of differentiating molecular markers. The most common molecular tests in clinical use are Afirma(®) Gene Expression Classifier (GEC) and Thyroseq(®) V2. Despite the rapidly developing field of molecular markers,...
Guardat en:
| Publicat a: | Front Endocrinol (Lausanne) |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5915469/ https://ncbi.nlm.nih.gov/pubmed/29720964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00179 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|